Solid Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
A live webcast of the presentation will be available on the Events page of the Investors section of the Company website or by clicking here. A webcast replay will be archived for 30 days on the Events ...
Solid Biosciences Outpaces Competitors In Duchenne Gene Therapy Development
Solid Biosciences advances gene therapies for muscular and cardiac diseases, gaining FDA clearance for SGT-212 and targeting ...
Charity makes £10k pledge to send Scots mum-of-three battling life-changing illnesses to ...
Glasgow-based charity The Emmie Smillie Charity Foundation has donated £10,000 towards a fundraiser to send Danielle Gardiner ...
Solid Bio draws buy from Truist on valuation and catalysts
Truist launched its coverage of gene therapy developer Solid Biosciences (NASDAQ:SLDB) on Wednesday with a Buy recommendation ...
MedPage Today5 小时
Varipulse Heart Device Procedures Paused After Safety Events
In that single-arm study, the rate of primary adverse events within 7 days of ablation was 2.9%, with the most common ...
News Medical on MSN17 小时
Extended Paxlovid courses show mixed results for long COVID symptoms
A study indicates that longer Paxlovid treatments could improve long COVID symptoms in some patients, highlighting the need ...
argenx (NASDAQ:ARGX) Given New $725.00 Price Target at Piper Sandler
(NASDAQ:ARGX – Free Report) had its price target lifted by Piper Sandler from $620.00 to $725.00 in a research report report published on Tuesday morning,Benzinga reports. The brokerage currently has ...